UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934
Date of report (Date of earliest event reported): November 13, 2026
ClearOne, Inc.
(Exact name of registrant as specified in its charter)
|
Nevada
|
|
001-33660
|
|
87-0398877
|
|
(State or Other Jurisdiction of Incorporation)
|
|
(Commission File Number)
|
|
(I.R.S. Employer Identification No.)
|
|
7533 S Center View Ct. # 5311, West Jordan, Utah
|
|
84084
|
|
(Address of principal executive offices)
|
|
(Zip Code)
|
+1 (801) 975-7200
(Registrant’s telephone number, including area code)
Not applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
|
☐
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
☐
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
☐
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
☐
|
Pre-commencement communication pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Securities Registered Pursuant to Section 12(b) of the Act:
|
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
|
Common Stock, $0.001
|
CLRO
|
The NASDAQ Capital Market
|
Item 1.01 Entry into a Material Definitive Agreement.
On November 13, 2026, ClearOne, Inc. (the “Company”) entered into private placement subscription agreements (each, a “Subscription Agreement”) with certain investors, pursuant to which the investors subscribed for an aggregate of 688,885 shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”) at a purchase price of $4.00 per share, for aggregate gross proceeds of $2,755,540. The Subscription Agreements contain customary representations, warranties and acknowledgements of the investors. The Subscription Agreements are substantially identical in all material respects other than the identity of the investor and the number of shares purchased.
The information set forth in Item 3.02 of this Current Report on Form 8-K regarding the Debt Settlement Agreement (as defined below), the Debt Conversion (as defined below) and the Private Placement (as defined below) is incorporated by reference into this Item 1.01.
Item 3.02 Unregistered Sales of Equity Securities.
On November 13, 2026, the Company entered into a Debt Settlement Agreement (the “Debt Settlement Agreement”) and a Subscription Agreement with First Finance, pursuant to which the Company agreed to issue an aggregate of 499,999 shares of Common Stock to First Finance at a deemed price of $4.00 per share, consisting of (i) 311,114 shares of Common Stock issued in full and final satisfaction of the aggregate amount of $1,244,458 of indebtedness owed by the Company to First Finance, consisting of $1,200,000 in principal and $44,458 in accrued interest (the “Debt Conversion”), and (ii) 188,885 shares of Common Stock purchased by First Finance for $755,540 in cash (the “Cash Purchase”). The Debt Conversion closed on November 17, 2026 upon the issuance of Common Stock to First Finance.
On November 17, 2026, the Company also completed a private placement of an aggregate of 500,000 shares of Common Stock to other accredited investors at a purchase price of $4.00 per share for aggregate gross proceeds of $2,000,000 (together with the Cash Purchase, the “Private Placement”). In total, the Company issued 999,999 shares of Common Stock in the Debt Conversion and the Private Placement for aggregate consideration of $3,999,998, including aggregate cash proceeds of $2,755,540. Following the closing, the Company had 3,675,411 shares of Common Stock outstanding. The Company intends to use the net proceeds from the Private Placement for working capital and general corporate purposes.
The Common Stock issued in the Debt Conversion and the Private Placement have not been registered under the Securities Act, and were offered and sold in reliance upon the exemption from registration provided by Section 4(a)(2) of the Securities Act and Rule 506(b) of Regulation D promulgated thereunder, as well as Regulation S for offshore investors.
The foregoing descriptions of the Debt Settlement Agreement and the Subscription Agreements do not purport to be complete and are qualified in their entirety by reference to the full text of the Debt Settlement Agreement and the form of Subscription Agreement, which are filed as Exhibits 10.1 and 10.2, respectively, to this Current Report on Form 8-K and incorporated herein by reference.
Item 7.01 Regulation FD Disclosure.
As previously disclosed, on April 7, 2026, the Company received a notice from the Listing Qualifications Department (the “Staff”) of the Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that the Company no longer complied with the continued listing requirements set forth in Nasdaq Listing Rule 5550(b). On October 8, 2026, the Company received a Staff determination letter notifying the Company that it had not demonstrated compliance with the $2,500,000 minimum stockholders’ equity requirement for continued listing set forth under Nasdaq Listing Rule 5550(b)(1) (the “Stockholders’ Equity Requirement”) because the Company had not completed the remedial actions contemplated by the compliance plan submitted to Nasdaq on May 22, 2026. Accordingly, the Staff determined to delist the Company’s securities from The Nasdaq Capital Market. On October 14, 2026, the Company requested a hearing before a Nasdaq Hearings Panel (the “Panel”) which stayed the suspension of the Common Stock pending the Panel’s decision, and paid a non-refundable appeal fee of $20,000. The hearing before the Panel is scheduled for November 17, 2026. There can be no assurance that the Panel will grant the Company’s request for continued listing or that the Company will regain compliance with the Nasdaq’s continued listing requirements. If the Panel does not grant the Company’s request, the Common Stock would be delisted from Nasdaq.
The Company is providing the unaudited pro forma condensed consolidated balance sheet as of September 30, 2026 and the accompanying notes furnished as Exhibit 99.1 to this Current Report on Form 8-K (the “Pro Forma Information”). The Pro Forma Information gives effect to the Debt Conversion and the Private Placement as if they had occurred on September 30, 2026. It reflects pro forma stockholders’ equity of $3,282,000, exceeding the Stockholders’ Equity Requirement.
Nasdaq will continue to monitor the Company’s ongoing compliance with the Stockholders’ Equity Requirement and, if at the time of its next periodic report the Company does not evidence compliance, the Company may be subject to delisting. The Company’s next periodic report will be its Annual Report on Form 10-K for the year ending December 31, 2026. The Company intends to submit this Current Report on Form 8-K to the Panel in support of a determination that the Company has regained compliance with the Stockholders’ Equity Requirement. This Current Report on Form 8-K and the Pro Forma Information are being provided in connection with the Company’s request for a favorable Panel determination. They do not constitute Nasdaq confirmation that the deficiency has been resolved or that the delisting proceedings have been terminated.
Based on the Debt Conversion, Private Placement and management’s assessment of the Company’s financial condition, the Company believes that it has regained compliance with the Stockholders’ Equity Requirement. The Company has requested that the Panel resolve the previously disclosed stockholders’ equity deficiency and confirm the Company’s compliance. There can be no assurance that the Panel or Nasdaq will determine that the Company has regained compliance, that any such determination will not be subject to conditions or a monitoring period, or that the Company will be able to maintain compliance with the Stockholders’ Equity Requirement or Nasdaq’s other continued listing requirements.
The Pro Forma Information was prepared by the Company’s financial personnel and is the responsibility of management. It is preliminary, unaudited and based on information available as of November 17, 2026. The presentation does not include all financial statements and disclosures required by generally accepted accounting principles in the United States (“U.S. GAAP”) and should not be viewed as a substitute for the Company’s financial statements prepared in accordance with U.S. GAAP. It should be read together with the Company’s previously filed financial statements and related notes.
The information remains subject to the completion of financial statement preparation, account reconciliations, closing procedures and the finalization of estimates and accounting analyses, as well as adjustments arising from the independent registered public accounting firm’s review of the Company’s quarterly financial statements and audit of its annual financial statements. Potential adjustments include the allocation of financing proceeds and offering costs; accrued liabilities; compensation expense; and other financial statement items. Final reported amounts may differ materially from the preliminary amounts presented, and any difference could affect the Company’s assessment of compliance with the Stockholders’ Equity Requirement.
The Pro Forma Information reflects only the specified transactions and assumptions described in Exhibit 99.1. It is not a representation of the Company’s actual financial position on November 17, 2026, a projection of results for the year ending December 31, 2026, or an assurance of continued listing. Further operating losses, dividends, expenses or other charges may reduce stockholders’ equity. Investors are cautioned against placing undue reliance on this preliminary information.
The information in this Item 7.01, including Exhibit 99.1, is furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) or otherwise subject to the liabilities of that section. It shall not be incorporated by reference into any filing under the Securities Act or the Exchange Act, except to the extent expressly incorporated by specific reference in that filing. This report does not constitute an offer to sell or a solicitation of an offer to buy any securities. The Private Placement securities have not been registered under the Securities Act and may be offered or sold only pursuant to registration or an applicable exemption.
Forward-Looking Statements
This Current Report on Form 8-K contains forward-looking statements. To the extent applicable, the Company intends these statements to be covered by the safe harbor provisions of Section 27A of the Securities Act, and Section 21E of the Exchange Act. Forward-looking statements include expectations regarding final financial reporting and accounting treatment; the timing and outcome of Nasdaq’s and the Panel’s review; the Company’s ability to regain and maintain compliance with Nasdaq’s continued listing requirements; and future stockholders’ equity, financial condition and capital needs. Words such as “believes,” “expects,” “estimates,” “anticipates,” “intends” and “may” and similar expressions may identify such statements.
These statements are based on current expectations and assumptions and involve risks and uncertainties that may cause actual outcomes to differ materially. Those risks include adjustments identified during closing, review and audit procedures; differences between estimated and actual offering costs; additional operating losses; Nasdaq’s exercise of discretion in evaluating both current equity and the ability to sustain compliance; additional conditions or information required by Nasdaq; an adverse Panel determination; the Company’s ability to satisfy other listing standards, obtain required stockholder approvals and comply with its financing and registration rights obligations; and the availability of additional capital if needed. Additional risks are described in the Company’s Annual Report on Form 10-K for the year ended December 31, 2025, and its subsequent reports and other filings with the Securities and Exchange Commission.
Forward-looking statements are not guarantees of future performance or of a favorable Nasdaq determination and speak only as of the date made. Except as required by applicable law, the Company undertakes no obligation to publicly update or revise any forward-looking statement as a result of new information, future events or otherwise.
Item 9.01 Financial Statements and Exhibits
(d) Exhibits
|
Exhibit Number
|
|
Exhibit Title
|
| 10.1 |
|
Debt Settlement and Subscription Agreement, dated November 13, 2026 by and between ClearOne, Inc. and First Finance Ltd. |
| 10.2 |
|
Form of Subscription Agreement, dated November 13, 2026, by and between ClearOne, Inc. and each of the investors party thereto. |
| 99.1 |
|
Unaudited Pro Forma Condensed Consolidated Balance Sheet as of September 30, 2026 and accompanying notes. |
|
104
|
|
The cover page from this Current Report on Form 8-K, formatted in Inline XBRL.
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
CLEARONE, INC.
|
|
|
|
|
|
Date: November 17, 2026
|
By:
|
/s/ Simon Brewer
|
|
|
|
Simon Brewer
|
|
|
|
Chief Financial Officer
|